Trustees Of Columbia University In The City Of New York Rapt Therapeutics, Inc. Transaction History
Trustees Of Columbia University In The City Of New York
- $46.9 Million
- Q4 2023
A detailed history of Trustees Of Columbia University In The City Of New York transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Trustees Of Columbia University In The City Of New York holds 73,383 shares of RAPT stock, worth $223,818. This represents 3.88% of its overall portfolio holdings.
Number of Shares
73,383
Previous 73,383
-0.0%
Holding current value
$223,818
Previous $1.22 Million
49.55%
% of portfolio
3.88%
Previous 2.41%
Shares
5 transactions
Others Institutions Holding RAPT
# of Institutions
148Shares Held
29.2MCall Options Held
709KPut Options Held
1.06M-
Column Group LLC San Francisco, CA2.68MShares$8.18 Million15.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$7.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$7.54 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.03MShares$6.19 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.91MShares$5.81 Million0.0% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $90.5M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...